Da Rentang\'s announcement on the progress of transferring 15% of the shares and related transactions of Tianjin Pharmaceutical Group Finance Co., Ltd. through public delisting
Da Rentang\'s announcement on the intention to transfer 15% of the shares and related transactions of Tianjin Pharmaceutical Group Finance Co., Ltd. through public delisting
Sino-Singapore Pharmaceutical: Announcement on the implementation of the company's annual equity allocation in 2021
Announcement on the implementation of the annual distribution of rights and interests of the company in 2021
Sino-Singapore Pharmaceutical: Announcement of Sino-Singapore Pharmaceutical's 2021 Profit Distribution Plan
Sino-Singapore Pharmaceutical: Announcement of the Seventh Board of Directors Resolutions in 2014
Sino-Singapore Pharmaceutical: Announcement of the Third Board of Directors Resolutions in 2014
Sino-Singapore Pharmaceutical: Announcement on Transactions Related to the Transfer of Shares in Central Pharmaceutical
Sino-Singapore Pharmaceutical: Announcement on Related Transactions to Acquire Shares in Hongrentang Pharmaceutical
Sino-Singapore Pharmaceutical: Announcement on Related Transactions Relating to the Transfer of Shares in Jinkang Pharmaceutical
Sino-Singapore Pharmaceutical: Announcement of the Eighth Board of Directors Resolutions in 2011
Sino-Singapore Pharmaceutical: Announcement on Transactions Related to the Transfer of Shares in Central Pharmaceutical
Sino-Singapore Pharmaceutical: Notice of Abnormal Fluctuations in Stock Trading
Sino-Singapore Pharmaceutical: Notice of Abnormal Fluctuations in Stock Trading
*ST Sino-Singapore: Notice of Abnormal Fluctuations in Stock Trading
*ST Sino-Singapore: Notice of Abnormal Fluctuations in Stock Trading
*ST Sino-Singapore: Notice of Abnormal Fluctuations in Stock Trading
*ST Sino-Singapore: Notice of Abnormal Fluctuations in Stock Trading
*ST Sino-Singapore: Notice of Abnormal Fluctuations in Stock Trading
*ST Sino-Singapore: Notice of Abnormal Fluctuations in Stock Trading
No Data